Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Teva exec upbeat on biogenerics in 2009
Corporate News Releases - The Healthcare Sales & Marketing Network, 12/24/08
The top U.S. executive of Teva Pharmaceutical Industries Ltd said on Tuesday that there was a "very good chance" of U.S. legislation passing next year that would pave the way for generic versions of biotechnology drugs.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
PR distribution service for the biotech industry
b3c newswire, 12/07/09
Safety First in Biotech Development
BioPharm, 12/03/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Article Search
Sponsor